Clinical Trial

Heparin vs Placebo for Cardiac Catheterization

Name: Heparin vs Placebo for Cardiac Catheterization — clinical trial record (NCT04374799)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Patients undergoing cardiac catheterization will be randomized to 3 groups: no anticoagulant, low dose anticoagulant and high dose anticoagulant.

Protocol Amendment History 5 amendments

This ClinicalTrials.gov record has been amended 5 times since 2020-05-01; most recent amendment 2026-02-18.

Status change: Not Yet Recruiting → Recruiting 2020-10-06

Trial Details

NCT Number	NCT04374799
Lead Sponsor	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions	Cardiac Disease
Enrollment	1,623 participants
Start Date	2020-10-05
Primary Completion	2026-08 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-02-20